R&D | October 28, 2025
MilliporeSigma partners with Promega to advance 3-D cell drug discovery technologies
Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies
Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies
Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
Medroxyprogesterone acetate-SC is a three-month contraceptive that can be administered by healthcare workers or self-injected after appropriate training
This partnership marks a significant step in strengthening Healthium’s position in the cardiac care segment
Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030
The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the US
Subscribe To Our Newsletter & Stay Updated
